Martin Filipits Selected Research

Martin Filipits Research Topics

Disease

60	Neoplasms (Cancer) 01/2022 - 03/2003
37	Breast Neoplasms (Breast Cancer) 01/2024 - 03/2003
32	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2023 - 09/2006
13	Lung Neoplasms (Lung Cancer) 12/2021 - 09/2006
11	Colorectal Neoplasms (Colorectal Cancer) 11/2021 - 10/2003
6	Adenocarcinoma of Lung 01/2021 - 07/2009
5	Glioblastoma (Glioblastoma Multiforme) 11/2020 - 01/2010
4	Adenocarcinoma 12/2015 - 08/2007
3	Leukemia 01/2019 - 03/2013
3	Malignant Mesothelioma 10/2014 - 05/2011
3	Neoplasm Metastasis (Metastasis) 03/2014 - 09/2003
3	Carcinoma (Carcinomatosis) 01/2012 - 01/2003
2	Pathologic Complete Response 01/2021 - 07/2017
2	Ovarian Neoplasms (Ovarian Cancer) 05/2015 - 01/2012
2	Mesothelioma 10/2014 - 05/2011
2	Squamous Cell Carcinoma of Head and Neck 04/2013 - 01/2012
2	Oropharyngeal Neoplasms 04/2013 - 01/2012
2	Multiple Myeloma 12/2003 - 02/2003
1	Residual Neoplasm 01/2021
1	Ductal Carcinoma 10/2019
1	Disease Progression 09/2017
1	Ependymoma 09/2017

Drug/Important Bio-Agent (IBA)

13	Hormones (Hormone)IBA 01/2024 - 10/2003
13	ErbB Receptors (EGF Receptor)IBA 07/2023 - 01/2008
13	Formaldehyde (Formol)FDA Link 01/2022 - 10/2009
13	ParaffinIBA 01/2022 - 10/2009
13	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2007
12	Estrogen ReceptorsIBA 01/2022 - 03/2003
11	Proteins (Proteins, Gene)FDA Link 01/2016 - 01/2003
9	Tamoxifen FDA LinkGeneric 01/2022 - 10/2003
9	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 09/2006
8	Tyrosine Kinase InhibitorsIBA 07/2023 - 01/2009
7	DNA (Deoxyribonucleic Acid)IBA 11/2020 - 01/2010
5	osimertinibIBA 01/2021 - 01/2018
5	PlatinumIBA 04/2016 - 01/2008
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2023 - 10/2003
4	human ERBB2 proteinIBA 11/2021 - 03/2014
4	Cyclin D1IBA 01/2018 - 07/2007
4	multidrug resistance-associated protein 1IBA 07/2007 - 09/2003
3	Circulating Tumor DNAIBA 01/2022 - 01/2021
3	B7-H1 AntigenIBA 04/2021 - 08/2015
3	Phenobarbital (Luminal)FDA Link 11/2020 - 03/2012
3	Trastuzumab (Herceptin)FDA Link 01/2018 - 10/2013
3	Anastrozole (Arimidex)FDA LinkGeneric 03/2015 - 12/2011
3	TOR Serine-Threonine KinasesIBA 01/2012 - 08/2007
3	Cyclin D3IBA 07/2007 - 03/2002
2	Docetaxel (Taxotere)FDA Link 11/2023 - 10/2013
2	Immune Checkpoint InhibitorsIBA 04/2021 - 08/2015
2	AnthracyclinesIBA 01/2021 - 10/2003
2	L-BLP25IBA 01/2021 - 01/2020
2	Taxoids (Taxanes)IBA 01/2021 - 01/2012
2	Fluorouracil (Carac)FDA LinkGeneric 11/2020 - 10/2003
2	MethyltransferasesIBA 11/2020 - 01/2010
2	Goserelin (Zoladex)FDA Link 11/2020 - 10/2003
2	Methotrexate (Mexate)FDA LinkGeneric 11/2020 - 10/2003
2	O-(6)-methylguanineIBA 11/2020 - 01/2010
2	Progesterone Receptors (Progesterone Receptor)IBA 10/2020 - 03/2003
2	Telomerase (Telomerase Reverse Transcriptase)IBA 06/2020 - 09/2017
2	Vinorelbine (Navelbine)FDA LinkGeneric 01/2019 - 01/2016
2	LigandsIBA 11/2018 - 08/2015
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 02/2015 - 10/2010
2	Mitogen-Activated Protein KinasesIBA 10/2014 - 06/2009
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 05/2014 - 09/2011
2	MTOR InhibitorsIBA 12/2012 - 08/2007
2	temsirolimus FDA Link 12/2012 - 05/2011
2	Everolimus FDA Link 12/2012 - 01/2012
2	RNA (Ribonucleic Acid)IBA 10/2012 - 09/2011
2	Bevacizumab (Avastin)FDA Link 08/2012 - 01/2009
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 02/2005 - 09/2003
1	Epirubicin (Ellence)FDA LinkGeneric 11/2023
1	Estrogen Receptor alphaIBA 01/2022
1	Epidermal Growth Factor (EGF)IBA 10/2020
1	Cancer VaccinesIBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 10/2019
1	CrizotinibIBA 01/2019
1	Cell-Free Nucleic AcidsIBA 01/2019
1	AfatinibIBA 01/2019
1	lorlatinibIBA 01/2019
1	Messenger RNA (mRNA)IBA 09/2017
1	NKP-1339IBA 01/2017
1	IndazolesIBA 01/2017
1	SodiumIBA 01/2017
1	Tumor Biomarkers (Tumor Markers)IBA 03/2016
1	alectinibIBA 12/2015
1	TensinsIBA 08/2015
1	HLA-DR Antigens (HLA-DR)IBA 08/2015
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 08/2015
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 05/2015
1	EnzymesIBA 05/2015

Therapy/Procedure

43	Therapeutics 01/2024 - 10/2003
23	Drug Therapy (Chemotherapy) 01/2021 - 02/2003
12	Adjuvant Chemotherapy 07/2019 - 09/2006
4	Neoadjuvant Therapy 11/2023 - 10/2003
3	Immunotherapy 11/2023 - 01/2020
2	Precision Medicine 12/2015 - 05/2013
2	Radiotherapy 10/2014 - 05/2011
1	Palliative Care (Palliative Therapy) 01/2020
1	Aftercare (After-Treatment) 01/2020
1	Salvage Therapy 01/2016
1	Combined Modality Therapy 01/2016